← all drugs

Cefotaxime Sodium Powder, for Solution

in shortage · Anti-Infective · Snapshot: 2026-10-09

Day 4,252

of this shortage, counting from the FDA's first posting on 02/17/2015

Manufacturers listed
Hikma Pharmaceuticals USA, Inc., SteriMax, Inc.
Reported reason(s)
Demand increase for the drug
Machine-readable
JSON for this drug

Presentations (6)

PresentationCompanyAvailabilityUpdated
Cefotaxime Sodium, Powder, for Solution, 2 g (NDC 0143-9933-25)Hikma Pharmaceuticals USA, Inc. Unavailable 09/18/2026
Cefotaxime Sodium, Powder, for Solution, 1 g (NDC 0143-9931-25)Hikma Pharmaceuticals USA, Inc. Unavailable 09/18/2026
Cefotaxime Sodium, Powder, for Solution, 10 g (NDC 0143-9935-01)Hikma Pharmaceuticals USA, Inc. Unavailable 09/18/2026
Cefotaxime Sodium, Powder, for Solution, 2 g (NDC 21586-012-02)SteriMax, Inc. Available 06/15/2026
Cefotaxime Sodium, Powder, for Solution, 1 g (NDC 21586-011-02)SteriMax, Inc. Available 06/15/2026
Cefotaxime Sodium, Powder, for Solution, 500 mg (NDC 0143-9930-10)Hikma Pharmaceuticals USA, Inc. Unavailable 09/18/2026

History

Daily tracking of this drug began 2026-08-25 (the first day of the archive). No change to its FDA listing has been observed since.

Each daily snapshot is compared with the one before it; status changes, availability-wording revisions, and arrivals or removals are listed here. A change the FDA makes and reverses between two snapshots is not seen. Every daily record is kept in the public repository.

Not medical advice. ShortSupply republishes the FDA's drug-shortage data with history added. Talk to your pharmacist or prescriber about your situation — never change medication based on this site.